RMD Kronos AI forecast
A 30-trading-day price forecast for ResMed Inc. (RMD) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts ResMed Inc. at $211.48 on 2026-12-08, −15.7% from the last close of $250.80 on 2026-10-27. Eight out of ten sampled paths end between $197.18 and $213.36, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of RMD
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $256.03 | $245.92 | $258.65 |
| 2026-11-10 | $235.36 | $225.21 | $241.39 |
| 2026-11-17 | $227.44 | $212.98 | $234.95 |
| 2026-11-24 | $216.24 | $203.00 | $224.94 |
| 2026-12-01 | $213.25 | $204.14 | $221.61 |
| 2026-12-08 | $211.48 | $197.18 | $213.36 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for RMD?
- Kronos AI's median forecast for RMD is $211.48 in 30 trading days, −15.7% from the last close, with a 10–90% range of $197.18 to $213.36.
- Is the RMD Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- SYK — Stryker Corporation
- MMM — 3M Company
- BSX — Boston Scientific Corporation
- BDX — Becton Dickinson and Company
- MDLN — Medline Inc.
- DXCM — DexCom Inc.